Literature DB >> 19108278

The biological properties of the optical isomers of propranolol and their effects on cardiac arrhythmias.

A M Barrett, V A Cullum.   

Abstract

1. The optical isomers of propranolol have been compared for their beta-blocking and antiarrhythmic activities.2. In blocking the positive inotropic and chronotropic responses to isoprenaline, (+)-propranolol had less than one hundredth the potency of (-)-propranolol. At dose levels of (+)-propranolol which attenuated the responses to isoprenaline, there was a significant prolongation of the PR interval of the electrocardiogram.3. The metabolic responses to isoprenaline in dogs (an increase in circulating glucose, lactate and free fatty acids) were all blocked by (-)-propranolol. (+)-Propranolol had no effect on fatty acid mobilization but significantly reduced the increments in both lactate and glucose.4. Both isomers of propranolol possessed similar depressant potency on isolated atrial muscle taken from guinea-pigs.5. The isomers of propranolol exhibited similar local anaesthetic potencies on an isolated frog nerve preparation at a level approximately three times that of procaine. The racemic compound was significantly less potent than either isomer.6. Both isomers of propranolol were capable of preventing adrenaline-induced cardiac arrhythmias in cats anaesthetized with halothane, but the mean dose of (-)-propranolol was 0.09+/-0.02 mg/kg whereas that of (+)-propranolol was 4.2+/-1.2 mg/kg. At the effective dose level of (+)-propranolol there was a significant prolongation of the PR interval of the electrocardiogram. Blockade of arrhythmias with both isomers was surmountable by increasing the dose of adrenaline.7. Both isomers of propranolol were also capable of reversing ventricular tachycardia caused by ouabain in anaesthetized cats and dogs. The dose of (-)-propranolol was significantly smaller than that of (+)-propranolol in both species but much higher than that required to produce evidence of beta-blockade.8. The implications of these results are discussed.

Entities:  

Year:  1968        PMID: 19108278      PMCID: PMC1703450          DOI: 10.1111/j.1476-5381.1968.tb07949.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

2.  Adrenergic beta receptors and plasma free fatty acids.

Authors:  T Zsoter; H Tom; M Kraml; D Dvornik
Journal:  J Pharmacol Exp Ther       Date:  1966-06       Impact factor: 4.030

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  Studies on the mode of action of clofibrate: effects on hormone-induced changes in plasma free fatty acids, cholesterol, phospholipids and total esterified fatty acids in rats and dogs.

Authors:  A M Barrett; J M Thorp
Journal:  Br J Pharmacol Chemother       Date:  1968-02

5.  Interaction of beta-receptor blocking agents with the nerve blocking effects of procaine in vitro.

Authors:  G Aberg; I Welin
Journal:  Life Sci       Date:  1967-05-01       Impact factor: 5.037

6.  The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomers.

Authors:  L S Whitsitt; B R Lucchesi
Journal:  Life Sci       Date:  1967-05-01       Impact factor: 5.037

7.  Inhibition by butoxamine, propranolol and MJ1999 of the glycogenolytic action of the catecholamines in the rat.

Authors:  R A Salvador; S A April; L Lemberger
Journal:  Biochem Pharmacol       Date:  1967-10       Impact factor: 5.858

8.  The effect of a beta-adrenergic receptor antagonist (H 56-28) on lipid mobilization.

Authors:  P Björntorp; L Ek; S Olsson; G Schröder
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

9.  Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.

Authors:  W W Parmley; E Braunwald
Journal:  J Pharmacol Exp Ther       Date:  1967-10       Impact factor: 4.030

10.  Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.

Authors:  B R Lucchesi; L S Whitsitt; N L Brown
Journal:  Can J Physiol Pharmacol       Date:  1966-07       Impact factor: 2.273

View more
  49 in total

1.  Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting.

Authors:  Emma S Wharfe; Catherine L Winder; Roger M Jarvis; Royston Goodacre
Journal:  Appl Environ Microbiol       Date:  2010-01-29       Impact factor: 4.792

2.  The effects of the propranolol enantiomers on the intracardiac electrophysiological activities of Langendorff perfused hearts.

Authors:  G Stark; U Stark; A Lueger; H Bertuch; E Pilger; B Pietsch; H A Tritthart; W Lindner
Journal:  Basic Res Cardiol       Date:  1989 Sep-Oct       Impact factor: 17.165

3.  Contribution of the liver to overall elimination of propranolol.

Authors:  C F George; M L Orme; P Buranapong; D Macerlean; A M Breckenridge; C T Dollery
Journal:  J Pharmacokinet Biopharm       Date:  1976-02

4.  Effect of propranolol on ventricular repolarization and refractoriness: role of beta-blockade versus direct membrane effects.

Authors:  D E Euler; P J Scanlon
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

5.  Comparative study of the effects of acebutolol, atenolol, d-propranolol and dl,-propranolol on the alterations in energy metabolism caused by ischemia and reperfusion: a 31P NMR study on the isolated rat heart.

Authors:  N Lavanchy; J Martin; A Rossi
Journal:  Cardiovasc Drugs Ther       Date:  1988-11       Impact factor: 3.727

6.  Modulation of dexamphetamine-induced compulsive gnawing--including the possible involvement of presynaptic alpha-adrenoreceptors.

Authors:  K V Thomas; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

7.  Effects of propranolol on conditioned suppression, discriminated punishment and discriminated non-reward in the rat.

Authors:  P Salmon; J A Gray
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  Physiological role of endogenous amines in the modulation of ventricular automaticity in the guinea-pig.

Authors:  J Hume; B G Katzung
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

9.  Effects of beta-adrenoceptor antagonists on the firing rate of noradrenergic neurones in the locus coeruleus of the rat.

Authors:  C Dahlöf; G Engberg; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-08       Impact factor: 3.000

10.  Stimulation of renin secretion and calcium efflux from the isolated perfused cat kidney by noradrenaline after prolonged calcium deprivation.

Authors:  E Harada; R P Rubin
Journal:  J Physiol       Date:  1978-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.